ENANTA PHARMACEUTICALS INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENANTA PHARMACEUTICALS INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.93 | 34,237 | 1,367,111 | 1,459,209 | 1.5 M to 1.5 M (-2.29 %) |
| Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.93 | 11,069 | 441,994 | 471,803 | 482.9 K to 471.8 K (-2.29 %) |
| Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.93 | 8,283 | 330,747 | 353,037 | 361.3 K to 353 K (-2.29 %) |
| Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.92 | 112,826 | 4,391,064 | 1,493,446 | 1.6 M to 1.5 M (-7.02 %) |
| Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.92 | 36,478 | 1,419,684 | 482,872 | 519.4 K to 482.9 K (-7.02 %) |
| Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.92 | 27,297 | 1,062,369 | 361,320 | 388.6 K to 361.3 K (-7.02 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 39.51 | 33,602 | 1,327,591 | 1,572,670 | 1.6 M to 1.6 M (-2.09 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 39.51 | 10,865 | 429,269 | 508,485 | 519.4 K to 508.5 K (-2.09 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 39.51 | 8,130 | 321,211 | 380,487 | 388.6 K to 380.5 K (-2.09 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.00 | 5,034 | 201,360 | 1,606,272 | 1.6 M to 1.6 M (-0.31 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.00 | 1,628 | 65,120 | 519,350 | 521 K to 519.4 K (-0.31 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.00 | 1,218 | 48,720 | 388,617 | 389.8 K to 388.6 K (-0.31 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.51 | 33,602 | 1,327,591 | 1,572,670 | 1.6 M to 1.6 M (-2.09 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.51 | 10,865 | 429,269 | 508,485 | 519.4 K to 508.5 K (-2.09 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.51 | 8,130 | 321,211 | 380,487 | 388.6 K to 380.5 K (-2.09 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.00 | 5,034 | 201,360 | 1,606,272 | 1.6 M to 1.6 M (-0.31 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.00 | 1,628 | 65,120 | 519,350 | 521 K to 519.4 K (-0.31 %) |
| Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.00 | 1,218 | 48,720 | 388,617 | 389.8 K to 388.6 K (-0.31 %) |
| Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.19 | 6,388 | 256,704 | 1,611,306 | 1.6 M to 1.6 M (-0.39 %) |
| Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.19 | 2,066 | 83,023 | 520,978 | 523 K to 521 K (-0.39 %) |
| Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.19 | 1,546 | 62,126 | 389,835 | 391.4 K to 389.8 K (-0.40 %) |
| Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.32 | 6,388 | 257,555 | 1,611,306 | 1.6 M to 1.6 M (-0.39 %) |
| Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.32 | 5,066 | 204,254 | 520,978 | 526 K to 521 K (-0.96 %) |
| Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.32 | 1,546 | 62,332 | 389,935 | 391.5 K to 389.9 K (-0.39 %) |
| Feb 14 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.52 | 2,385 | 91,862 | 569,338 | 571.7 K to 569.3 K (-0.42 %) |
| Feb 14 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 37.81 | 3,415 | 129,113 | 571,723 | 575.1 K to 571.7 K (-0.59 %) |
| Feb 11 2014 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 36.61 | 9,280 | 339,741 | 9,280 | |
| Feb 10 2014 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 35.00 | 4,640 | 162,400 | 4,640 | |
| Feb 10 2014 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | A | 35.00 | 4,640 | 162,400 | 4,640 | |
| Feb 10 2014 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Option Exercise | A | 35.00 | 4,640 | 162,400 | 4,640 | |
| Feb 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Option Exercise | A | 32.43 | 70,000 | 2,270,100 | 70,000 |